Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
46 | 3 | VIROLOGY//HIV 1//AIDS RESEARCH AND HUMAN RETROVIRUSES | 102919 |
96 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//INFECTIOUS DISEASES | 26037 |
19036 | 1 | ETRAVIRINE//RILPIVIRINE//TMC125 | 547 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ETRAVIRINE | authKW | 2486017 | 14% | 55% | 78 |
2 | RILPIVIRINE | authKW | 1749440 | 10% | 53% | 57 |
3 | TMC125 | authKW | 617310 | 3% | 71% | 15 |
4 | PROTEASE INHIBITOR MONOTHERAPY | authKW | 410086 | 2% | 65% | 11 |
5 | LERSIVIRINE | authKW | 333346 | 2% | 64% | 9 |
6 | TMC278 | authKW | 333346 | 2% | 64% | 9 |
7 | DARUNAVIR | authKW | 300281 | 6% | 15% | 35 |
8 | DUAL ANTIRETROVIRAL THERAPY | authKW | 288082 | 1% | 100% | 5 |
9 | NRTI SPARING | authKW | 288082 | 1% | 100% | 5 |
10 | TREATMENT SIMPLIFICATION | authKW | 245823 | 1% | 53% | 8 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Infectious Diseases | 27857 | 67% | 0% | 364 |
2 | Virology | 6909 | 27% | 0% | 148 |
3 | Pharmacology & Pharmacy | 2873 | 43% | 0% | 233 |
4 | Immunology | 2339 | 32% | 0% | 174 |
5 | Microbiology | 1636 | 24% | 0% | 129 |
6 | Medicine, General & Internal | 29 | 5% | 0% | 28 |
7 | Toxicology | 15 | 2% | 0% | 13 |
8 | Health Care Sciences & Services | 1 | 1% | 0% | 4 |
9 | Primary Health Care | 0 | 0% | 0% | 1 |
10 | Health Policy & Services | 0 | 0% | 0% | 2 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HOSP JUAN FERNANDEZ | 129635 | 1% | 75% | 3 |
2 | COREVIH PAYS DE LA LOIRE | 115233 | 0% | 100% | 2 |
3 | HPEA MRT 3620 | 115233 | 0% | 100% | 2 |
4 | UF THER EUT IMMUNO INFECTIOL | 115233 | 0% | 100% | 2 |
5 | HIV UNIT | 85050 | 4% | 6% | 24 |
6 | DIBIC LUIGI SACCO | 83801 | 1% | 36% | 4 |
7 | MED SITE NECKER | 65842 | 1% | 29% | 4 |
8 | AAHIVE | 57616 | 0% | 100% | 1 |
9 | ACLI INT LTD | 57616 | 0% | 100% | 1 |
10 | ANRSINSERMUMR S 1136 | 57616 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HIV CLINICAL TRIALS | 63168 | 4% | 5% | 24 |
2 | AIDS REVIEWS | 45942 | 3% | 5% | 15 |
3 | ANTIVIRAL THERAPY | 45377 | 7% | 2% | 39 |
4 | HIV MEDICINE | 42263 | 5% | 3% | 29 |
5 | AIDS | 19122 | 10% | 1% | 54 |
6 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 13071 | 10% | 0% | 54 |
7 | NEW MICROBIOLOGICA | 9688 | 2% | 2% | 11 |
8 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 8021 | 5% | 1% | 25 |
9 | CURRENT HIV RESEARCH | 4343 | 1% | 1% | 8 |
10 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 4194 | 4% | 0% | 20 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ETRAVIRINE | 2486017 | 14% | 55% | 78 | Search ETRAVIRINE | Search ETRAVIRINE |
2 | RILPIVIRINE | 1749440 | 10% | 53% | 57 | Search RILPIVIRINE | Search RILPIVIRINE |
3 | TMC125 | 617310 | 3% | 71% | 15 | Search TMC125 | Search TMC125 |
4 | PROTEASE INHIBITOR MONOTHERAPY | 410086 | 2% | 65% | 11 | Search PROTEASE+INHIBITOR+MONOTHERAPY | Search PROTEASE+INHIBITOR+MONOTHERAPY |
5 | LERSIVIRINE | 333346 | 2% | 64% | 9 | Search LERSIVIRINE | Search LERSIVIRINE |
6 | TMC278 | 333346 | 2% | 64% | 9 | Search TMC278 | Search TMC278 |
7 | DARUNAVIR | 300281 | 6% | 15% | 35 | Search DARUNAVIR | Search DARUNAVIR |
8 | DUAL ANTIRETROVIRAL THERAPY | 288082 | 1% | 100% | 5 | Search DUAL+ANTIRETROVIRAL+THERAPY | Search DUAL+ANTIRETROVIRAL+THERAPY |
9 | NRTI SPARING | 288082 | 1% | 100% | 5 | Search NRTI+SPARING | Search NRTI+SPARING |
10 | TREATMENT SIMPLIFICATION | 245823 | 1% | 53% | 8 | Search TREATMENT+SIMPLIFICATION | Search TREATMENT+SIMPLIFICATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |